Local and systemic recurrence following total neoadjuvant therapy (TNT) and resection for borderline resectable and locally advanced pancreatic adenocarcinoma: Long-term follow up from two phase II studies.

Grace Ryan,Janet E. Murphy,Christine A Ulysse,Beow Y. Yeap,Jennifer Y. Wo,Colin D. Weekes,Jeffrey W. Clark,Jill N. Allen,Lawrence S. Blaszkowsky,Ryan D. Nipp,Lorraine C. Drapek,Aparna Raj Parikh,Christine Bolton,Jacob Maruna,Cristina R. Ferrone,Motaz Qadan,Keith D. Lillemoe,David P. Ryan,Carlos Fernandez-del-Castillo,Theodore S. Hong

Local and systemic recurrence following total neoadjuvant therapy (TNT) and resection for borderline resectable and locally advanced pancreatic adenocarcinoma: Long-term follow up from two phase II studies.

2021

4133Background: With the advent of FOLFIRINOX, the management of pancreatic cancer has undergone a profound change. There has been a shift to TNT with FOLFIRINOX followed by radiation and an attemp...

Keywords:

Adenocarcinoma
borderline resectable
locally advanced
Medicine
Pancreatic cancer
long term follow up
Neoadjuvant therapy
FOLFIRINOX
Radiology
Resection

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations